Reminder: Patient Engagement Advisory Committee meeting

Patient Affairs Staff (PAS)

Food and Drug Administration

U.S. Department of Health and Human Services

Reminder: FDA's Patient Engagement Advisory Committee Meeting - Nov. 15

The FDA Patient Engagement Advisory Committee will hold its second public meeting on November 15th. The Committee will discuss whether and how the FDA can harness patient-driven online and mobile platforms to better engage with patients and consumers, as well as to collect and evaluate real-world data in the form of health information provided by patients and consumers. The Patient Engagement Advisory Committee (PEAC) is the first FDA advisory committee focused wholly on patients and patient-related issues. Members, including patient representatives, a consumer representative, and a non-voting industry representative (selected based on the topic), provide advice to the Commissioner of the FDA on complex issues relating to medical devices, the regulation of devices, and their use by patients.

Date: Thursday, Nov 15th

Time: 8 am – 5 pm ET

Location: Hilton Washington DC North/Gaithersburg, 620 Perry Parkway in Gaithersburg, MD

Social Media: use #PEAC2018 to stay connected

The deadline to register to speak at the Open Public Hearing is Monday, October 15th.

To submit your request, email Letise.Williams@fda.hhs.gov the following information: 1. A brief statement of the general nature of the evidence or arguments you wish to present; 2. the names and addresses of proposed participants; and 3. the approximate time requested to make your presentation. You can also submit written comments. The deadline for submitting written comments is Oct. 23rd

More Information:

• PEAC meeting details: View the PEAC meeting page
• Interested in becoming a member of PEAC? Contact Letise Williams, Designated Federal Official, at Letise.Williams@fda.hhs.gov or 301-796-8398.

Interested in learning about ways patients can get involved at FDA? Contact FDA's Patient Affairs Staff at (301) 796-8460 or PatientAffairs@fda.gov.